Literature DB >> 10828345

Implication of atypical protein kinase C isozymes lambda and zeta in Ras mediated reorganization of the actin cytoskeleton and cyclin D1-induction.

K Hellbert1, S Kampfer, K Maly, F Hochholdinger, J Mwanjewe, G Baier, F Uberall, H H Grunicke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10828345     DOI: 10.1016/s0065-2571(99)00038-2

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


× No keyword cloud information.
  6 in total

1.  Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iota.

Authors:  J Mwanjewe; M Spitaler; M Ebner; M Windegger; M Geiger; S Kampfer; J Hofmann; F Uberall; H H Grunicke
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

Review 2.  The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

Authors:  Miguel Reina-Campos; Maria T Diaz-Meco; Jorge Moscat
Journal:  Cancer Cell       Date:  2019-08-29       Impact factor: 31.743

3.  PAK1 and aPKCzeta regulate myosin II-B phosphorylation: a novel signaling pathway regulating filament assembly.

Authors:  Liron Even-Faitelson; Shoshana Ravid
Journal:  Mol Biol Cell       Date:  2006-04-12       Impact factor: 4.138

Review 4.  Protein kinase C iota: human oncogene, prognostic marker and therapeutic target.

Authors:  Alan P Fields; Roderick P Regala
Journal:  Pharmacol Res       Date:  2007-05-05       Impact factor: 7.658

5.  Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity.

Authors:  Pramod P Naranatt; Shaw M Akula; Christopher A Zien; Harinivas H Krishnan; Bala Chandran
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Recurrent copy number gains drive PKCι expression and PKCι-dependent oncogenic signaling in human cancers.

Authors:  Yi Liu; Verline Justilien; Alan P Fields; Nicole R Murray
Journal:  Adv Biol Regul       Date:  2020-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.